101 related articles for article (PubMed ID: 7590493)
1. Serous psammocarcinoma of the ovary in an adolescent female.
Kelley JL; Capelle SC; Kanbour-Shakir A
Gynecol Oncol; 1995 Nov; 59(2):309-11. PubMed ID: 7590493
[TBL] [Abstract][Full Text] [Related]
2. Serous psammocarcinoma of the ovary: a case report and review of literature.
Giordano G; Gnetti L; Milione M; Piccolo D; Soliani P
Gynecol Oncol; 2005 Jan; 96(1):259-62. PubMed ID: 15589614
[TBL] [Abstract][Full Text] [Related]
3. Serous psammocarcinoma of the ovary: an unusual finding.
Rettenmaier MA; Goldstein BH; Epstein HD; Brown JV; Micha JP
Gynecol Oncol; 2005 Nov; 99(2):510-1. PubMed ID: 16051342
[TBL] [Abstract][Full Text] [Related]
4. Patterns of stromal invasion in ovarian serous tumors of low malignant potential (borderline tumors): a reevaluation of the concept of stromal microinvasion.
McKenney JK; Balzer BL; Longacre TA
Am J Surg Pathol; 2006 Oct; 30(10):1209-21. PubMed ID: 17001150
[TBL] [Abstract][Full Text] [Related]
5. Serous psammocarcinoma of the ovary and peritoneum: two case reports and review of the literature.
Alanbay I; Dede M; Ustün Y; Karaşahin E; Deveci S; Günhan O; Yenen MC
Arch Gynecol Obstet; 2009 Jun; 279(6):931-6. PubMed ID: 18982336
[TBL] [Abstract][Full Text] [Related]
6. A unique case of serous psammocarcinoma of the ovary presenting with pleural effusion and manifesting psammoma body implants in the pleural cavity and pericardium.
Tiro AV; Talukdar R; Lewis MG
Gynecol Oncol; 2009 Jun; 113(3):402-4. PubMed ID: 19345402
[TBL] [Abstract][Full Text] [Related]
7. Optimal debulking surgery is an independent prognostic factor in patients with FIGO IIIC primary epithelial ovarian carcinoma.
Wang PH; Yuan CC; Shyong WY; Chiang SC; Chao JY; Yen MS; Ng HT
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Mar; 63(3):220-5. PubMed ID: 10746418
[TBL] [Abstract][Full Text] [Related]
8. A unique case of ovarian psammocarcinoma with mediastinal, pulmonary, subcutaneous, and omental metastases.
Chase DM; Sparks DA; Gener M; Smith J
Arch Gynecol Obstet; 2009 Aug; 280(2):283-6. PubMed ID: 19096859
[TBL] [Abstract][Full Text] [Related]
9. Serous psammocarcinoma of the ovary and peritoneum.
Gilks CB; Bell DA; Scully RE
Int J Gynecol Pathol; 1990; 9(2):110-21. PubMed ID: 2332269
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
12. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
Ulbright TM
Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
[TBL] [Abstract][Full Text] [Related]
13. Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma.
Gilks CB; Ionescu DN; Kalloger SE; Köbel M; Irving J; Clarke B; Santos J; Le N; Moravan V; Swenerton K;
Hum Pathol; 2008 Aug; 39(8):1239-51. PubMed ID: 18602670
[TBL] [Abstract][Full Text] [Related]
14. Clinical factors and biomarkers in ovarian tumors development.
Vrabie CD; Petrescu A; Waller M; Dina I
Rom J Morphol Embryol; 2008; 49(3):327-38. PubMed ID: 18758637
[TBL] [Abstract][Full Text] [Related]
15. [Quantitative characteristics of stromal components in prognosis of ovarian cancer recurrences].
Novichkov EV; Votintsev AA
Arkh Patol; 2005; 67(4):29-31. PubMed ID: 16209295
[TBL] [Abstract][Full Text] [Related]
16. Platinum-based chemotherapy of high-risk stage I epithelial ovarian cancer following comprehensive surgical staging.
Rubin SC; Wong GY; Curtin JP; Barakat RR; Hakes TB; Hoskins WJ
Obstet Gynecol; 1993 Jul; 82(1):143-7. PubMed ID: 8515915
[TBL] [Abstract][Full Text] [Related]
17. Lymphatic vascular invasion in ovarian serous tumors of low malignant potential with stromal microinvasion: a case control study.
Sangoi AR; McKenney JK; Dadras SS; Longacre TA
Am J Surg Pathol; 2008 Feb; 32(2):261-8. PubMed ID: 18223329
[TBL] [Abstract][Full Text] [Related]
18. Ovarian nonsmall cell neuroendocrine carcinoma: a clinicopathologic and immunohistochemical study of 11 cases.
Veras E; Deavers MT; Silva EG; Malpica A
Am J Surg Pathol; 2007 May; 31(5):774-82. PubMed ID: 17460463
[TBL] [Abstract][Full Text] [Related]
19. Decision making in borderline ovarian tumors: report of a rare case of mesosigma psammocarcinoma.
Grimaldi L; Danzi M; Reggio S; Pannullo M; Danzi R; Lauria R
Ann Ital Chir; 2013 Sep; 84(ePub):. PubMed ID: 23995281
[TBL] [Abstract][Full Text] [Related]
20. The benefits of comprehensive surgical staging in the management of early-stage epithelial ovarian carcinoma.
Le T; Adolph A; Krepart GV; Lotocki R; Heywood MS
Gynecol Oncol; 2002 May; 85(2):351-5. PubMed ID: 11972399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]